Pfizer Canada strives to profoundly impact the health of Canadians through the discovery, development and delivery of medicines and vaccines. Our diverse portfolio offers a broad range of benefits and solutions to meet the needs of Canadians.
Crohn’s and Colitis Canada and Pfizer Canada Introduce the 2024 Diversity, Equity and Inclusion Awards Program in IBD Research
ELREXFIO™ is authorized by Health Canada for adults with relapsed or refractory multiple myeloma in Canada
Sumitomo Pharma and Pfizer Canada Announce Availability of MYFEMBREE® in Canada